Amyotrophic Lateral Sclerosis Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Amyotrophic Lateral Sclerosis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Amyotrophic Lateral Sclerosis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Amyotrophic Lateral Sclerosis Therapeutics Overall Market Size
2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size: 2021 VS 2028
2.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Amyotrophic Lateral Sclerosis Therapeutics Players in Global Market
3.2 Top Global Amyotrophic Lateral Sclerosis Therapeutics Companies Ranked by Revenue
3.3 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Amyotrophic Lateral Sclerosis Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Amyotrophic Lateral Sclerosis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Amyotrophic Lateral Sclerosis Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Riluzole
4.1.3 Edaravone (Radicava)
4.1.4 Other
4.2 By Type - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028
6.3.2 US Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.3.3 Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.3.4 Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028
6.4.2 Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.3 France Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.4 U.K. Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.5 Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.6 Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.8 Benelux Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028
6.5.2 China Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.5.3 Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.5.4 South Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.5.6 India Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028
6.6.2 Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.6.3 Argentina Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028
6.7.2 Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.7.3 Israel Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.7.5 UAE Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Mitsubishi Tanabe Pharma
7.1.1 Mitsubishi Tanabe Pharma Corporate Summary
7.1.2 Mitsubishi Tanabe Pharma Business Overview
7.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Mitsubishi Tanabe Pharma Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.2.4 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Mylan Pharma
7.3.1 Mylan Pharma Corporate Summary
7.3.2 Mylan Pharma Business Overview
7.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Mylan Pharma Key News
7.4 Apotex
7.4.1 Apotex Corporate Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.4.4 Apotex Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Apotex Key News
7.5 Glemark Generics
7.5.1 Glemark Generics Corporate Summary
7.5.2 Glemark Generics Business Overview
7.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.5.4 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Glemark Generics Key News
7.6 Covis Pharma
7.6.1 Covis Pharma Corporate Summary
7.6.2 Covis Pharma Business Overview
7.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.6.4 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Covis Pharma Key News
7.7 Sun Pharma
7.7.1 Sun Pharma Corporate Summary
7.7.2 Sun Pharma Business Overview
7.7.3 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.7.4 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Sun Pharma Key News
7.8 Lunan Pharma
7.8.1 Lunan Pharma Corporate Summary
7.8.2 Lunan Pharma Business Overview
7.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Lunan Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Amyotrophic Lateral Sclerosis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Amyotrophic Lateral Sclerosis Therapeutics Market Drivers in Global Market
Table 3. Amyotrophic Lateral Sclerosis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Amyotrophic Lateral Sclerosis Therapeutics in Global Market
Table 5. Top Amyotrophic Lateral Sclerosis Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Amyotrophic Lateral Sclerosis Therapeutics Product Type
Table 9. List of Global Tier 1 Amyotrophic Lateral Sclerosis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Mitsubishi Tanabe Pharma Corporate Summary
Table 31. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offerings
Table 32. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Product Offerings
Table 35. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Pharma Corporate Summary
Table 37. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offerings
Table 38. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Apotex Corporate Summary
Table 40. Apotex Amyotrophic Lateral Sclerosis Therapeutics Product Offerings
Table 41. Apotex Amyotrophic Lateral Sclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Glemark Generics Corporate Summary
Table 43. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Product Offerings
Table 44. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Covis Pharma Corporate Summary
Table 46. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offerings
Table 47. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Sun Pharma Corporate Summary
Table 49. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offerings
Table 50. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Lunan Pharma Corporate Summary
Table 52. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offerings
Table 53. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis Therapeutics Segment by Type in 2021
Figure 2. Amyotrophic Lateral Sclerosis Therapeutics Segment by Application in 2021
Figure 3. Global Amyotrophic Lateral Sclerosis Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2021
Figure 8. By Type - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Amyotrophic Lateral Sclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Apotex Amyotrophic Lateral Sclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
